The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial

M Gnant; G Pfeiler; H St?ger; B Mlineritsch; F Fitzal; M Balic; W Kwasny; M Seifert; M Stierer; P Dubsky; R Greil; G Steger; H Samonigg; C Fesl; R Jakesz

首页> 外文期刊>British Journal of Cancer >The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial

【24h】

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial

机译：体重指数对绝经后乳腺癌患者阿那曲唑扩大辅助内分泌治疗疗效的预测影响：一项随机ABCSG-6a试验分析

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:We investigated whether body mass index (BMI) can be used as a predictive parameter indicating patients who benefit from extended aromatase inhibitor (AI) treatment.

机译：背景：我们调查了体重指数（BMI）是否可以用作指示受益于延长的芳香化酶抑制剂（AI）治疗的患者的预测参数。

著录项

来源
《British Journal of Cancer》 |2013年第3期|共8页
作者
M Gnant; G Pfeiler; H St?ger; B Mlineritsch; F Fitzal; M Balic; W Kwasny; M Seifert; M Stierer; P Dubsky; R Greil; G Steger; H Samonigg; C Fesl; R Jakesz;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial (vol 35, pg 1041, 2017) [J] . Burris Howard A. Journal of Clinical Oncology . 2019,第4期

机译：佐剂Letrozole对蛋白质受体患者阳性阳性阳性，节点阳性早期乳腺癌患者的比较疗效和安全性：随机阶段III女性的最终结果与Anstrozole临床评价（Face）试验（Vol 35，PG 1041,2017）
2. Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial [J] . Smith Ian, Yardley Denise, Burris Howard, Journal of Clinical Oncology . 2017,第10期

机译：佐剂Letrozole对蛋白质激素受体阳性患者患者的辅助Letrozole对Zastrozole的比较疗效和安全性，节点阳性早期乳腺癌：随机阶段III女性的最终结果与Anstrozole临床评价（Face）试验
3. Extended Adjuvant Therapy With Anastrozole Among Postmenopausal Breast Cancer Patients: Results From the Randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a [J] . Raimund Jakesz Richard Greil Michael Gnant Marianne Schmid Werner Kwasny Ernst Kubista Brigitte Mlineritsch Christoph Tausch Michael Stierer Friedrich Hofbauer Karl Renner Christian Dadak Ernst Rücklinger Hellmut Samonigg and On behalf of the Austrian Breast and Colorectal Cancer Study Group Journal of the National Cancer Institute . 2007,第24期

机译：绝经后乳腺癌患者使用阿那曲唑扩大辅助治疗：奥地利乳腺癌和大肠癌随机研究小组6a试验的结果
4. Adjuvant Neutron Therapy in Complex Treatment of Patients with Locally Advanced Breast Cancer [C] . V. A. Lisin, V. V. Velikaya, Zh. A. Startseva, International Conference on Physics of Cancer : Interdisciplinary Problems and Clinical Applications . 2017

机译：佐剂中子治疗复杂治疗局部晚期乳腺癌患者
5. A time to question: A study of the information needs of postmenopausal breast cancer patients regarding endocrine therapy. [D] . TeBrake, Melissa Lynn. 2010

机译：问题时间：对绝经后乳腺癌患者有关内分泌治疗的信息需求的研究。
6. The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial [O] . M Gnant, G Pfeiler, H Stöger, 2013

机译：体重指数对绝经后乳腺癌患者阿那曲唑扩大辅助内分泌治疗疗效的预测影响：一项随机ABCSG-6a试验分析
7. Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: A Dutch TEAM trial analysis [O] . Nes J.G.H. van, Beex L.V. (Louk), Seynaeve C.M. (Caroline), 2015

机译：辅助用依西美坦或他莫昔芬治疗对绝经后乳腺癌患者的乳房X线照相乳腺密度的最小影响：荷兰TEAM试验分析

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial

摘要

著录项

相似文献

相关主题

期刊订阅